10x Genomics, Inc. TXG Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $638.78M-0.6% | $642.82M+0.2% | $641.81M-0.4% | $644.47M+3.2% | $624.66M+2.3% | ||
| $194.17M-2.4% | $198.94M-0.5% | $200.02M+1.7% | $196.59M-0.5% | $197.65M+0.7% | ||
| $444.61M+0.2% | $443.88M+0.5% | $441.79M-1.4% | $447.88M+4.9% | $427.01M+3.0% | ||
| 69.6%+0.6pp | 69.1%+0.2pp | 68.8%-0.7pp | 69.5%+1.1pp | 68.4%+0.5pp | ||
| $231.23M-3.1% | $238.63M-4.4% | $249.63M-3.5% | $258.61M-0.7% | $260.31M-1.7% | ||
| $292.78M-7.4% | $316.13M-5.2% | $333.34M-1.9% | $339.69M-2.5% | $348.3M+1.1% | ||
| $483.32M-4.3% | $504.87M-5.3% | $533.07M-2.8% | $548.4M-8.5% | $599.4M-1.6% | ||
| $483.32M-4.3% | $504.87M-5.3% | $533.07M-2.8% | $548.4M-8.5% | $599.4M-1.6% | ||
| -$38.7M+36.5% | -$60.99M+33.2% | -$91.28M+9.2% | -$100.53M+41.7% | -$172.39M+11.4% | ||
| -6.1%+3.4pp | -9.5%+4.7pp | -14.2%+1.4pp | -15.6%+12.0pp | -27.6%+4.3pp | ||
| $21.38M+6.6% | $20.05M+13.5% | $17.66M+1.3% | $17.44M-2.5% | $17.88M-5.5% | ||
| $19.46M-7.7% | $21.08M+15.9% | $18.19M-14.2% | $21.2M+11.7% | $18.99M+12.6% | ||
| -$19.25M+51.8% | -$39.91M+45.4% | -$73.09M+7.9% | -$79.33M+48.3% | -$153.4M+13.7% | ||
| $3.41M-6.3% | $3.64M+12.7% | $3.23M-38.8% | $5.27M+45.2% | $3.63M-26.3% | ||
| -$22.66M+48.0% | -$43.54M+42.9% | -$76.32M+9.8% | -$84.6M+46.1% | -$157.04M+14.0% | ||
| -3.5%+3.2pp | -6.8%+5.1pp | -11.9%+1.2pp | -13.1%+12.0pp | -25.1%+4.8pp | ||
| -$0.17+51.4% | -$0.35+44.4% | -$0.63+11.3% | -$0.71+45.8% | -$1.31+14.4% | ||
| -$0.17+51.4% | -$0.35+44.4% | -$0.63+11.3% | -$0.71+45.8% | -$1.31+14.4% | ||
| 503.1M+1.1% | 497.4M+0.9% | 493.1M+1.0% | 488.3M+0.9% | 483.9M+0.7% | ||
| 502.3M+1.1% | 496.6M+0.9% | 492.3M+1.0% | 487.5M+0.8% | 483.9M+0.7% | ||
| $40.7M-18.4% | $49.9M0.0% | $49.9M0.0% | $49.9M+442% | $9.2M— | ||
| —— | —— | $525K-86.1% | $3.77M+240% | $1.11M+154% | ||
| $231.23M-3.1% | $238.63M-4.4% | $249.63M-3.5% | $258.61M-0.7% | $260.31M-1.7% | ||
| $638.78M-0.6% | $642.82M+0.2% | $641.81M-0.4% | $644.47M+3.2% | $624.66M+2.3% | ||
| -$38.7M+36.5% | -$60.99M+33.2% | -$91.28M+9.2% | -$100.53M+41.7% | -$172.39M+11.4% | ||
| -$569K+97.7% | -$24.79M+56.1% | -$56.4M+15.8% | -$66.98M+51.4% | -$137.68M+13.2% | ||
| -$569K+97.7% | -$24.79M+56.1% | -$56.4M+15.8% | -$66.98M+51.4% | -$137.68M+13.2% | ||
| -0.1%+3.8pp | -3.9%+4.9pp | -8.8%+1.6pp | -10.4%+11.6pp | -22%+3.9pp | ||
| -$38.7M+36.5% | -$60.99M+33.2% | -$91.28M+9.2% | -$100.53M+41.7% | -$172.39M+11.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are 10x Genomics, Inc.'s profit margins?
- Gross margin is 69.6% and operating margin is -6.1%, with a -3.5% net margin.
- Where does 10x Genomics, Inc.'s income statement data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.